Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Study: Return on Investment in Innovative Medicines in Lithuania Is the Highest Among 29 European Countries

Summary by lrytas.lt
Every euro spent on innovative medicines in Europe creates an average of 5.67 euros in social and economic value. In Lithuania, this value reaches 11.2 euros – the highest indicator among the 29 countries studied, according to a study commissioned by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

lrytas.ltlrytas.lt

Study: Return on Investment in Innovative Medicines in Lithuania Is the Highest Among 29 European Countries

Every euro spent on innovative medicines in Europe creates an average of 5.67 euros in social and economic value. In Lithuania, this value reaches 11.2 euros – the highest indicator among the 29 countries studied, according to a study commissioned by the European Federation of Pharmaceutical Industries and Associations (EFPIA).

·Vilnius, Lithuania
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

lrytas.lt broke the news in Vilnius, Lithuania on Sunday, October 4, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Medical icon

Medical

Lithuania icon

Lithuania

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal